171 related articles for article (PubMed ID: 38246918)
1. RNPS1 stabilizes NAT10 protein to facilitate translation in cancer via tRNA ac
Wang X; Ling R; Peng Y; Qiu W; Chen D
Int J Oral Sci; 2024 Jan; 16(1):6. PubMed ID: 38246918
[TBL] [Abstract][Full Text] [Related]
2. Aberrant translation regulated by METTL1/WDR4-mediated tRNA N7-methylguanosine modification drives head and neck squamous cell carcinoma progression.
Chen J; Li K; Chen J; Wang X; Ling R; Cheng M; Chen Z; Chen F; He Q; Li S; Zhang C; Jiang Y; Chen Q; Wang A; Chen D
Cancer Commun (Lond); 2022 Mar; 42(3):223-244. PubMed ID: 35179319
[TBL] [Abstract][Full Text] [Related]
3. N4-acetylcytidine-dependent GLMP mRNA stabilization by NAT10 promotes head and neck squamous cell carcinoma metastasis and remodels tumor microenvironment through MAPK/ERK signaling pathway.
Liu Y; Wang X; Liu Y; Yang J; Mao W; Feng C; Wu X; Chen X; Chen L; Dong P
Cell Death Dis; 2023 Nov; 14(11):712. PubMed ID: 37914704
[TBL] [Abstract][Full Text] [Related]
4. NAT10-mediated ac
Miao D; Shi J; Lv Q; Tan D; Zhao C; Xiong Z; Zhang X
Cancer Commun (Lond); 2024 Mar; 44(3):361-383. PubMed ID: 38407929
[TBL] [Abstract][Full Text] [Related]
5. Acetyltransferase NAT10 regulates the Wnt/β-catenin signaling pathway to promote colorectal cancer progression via ac
Jin C; Wang T; Zhang D; Yang P; Zhang C; Peng W; Jin K; Wang L; Zhou J; Peng C; Tan Y; Ji J; Chen Z; Sun Q; Yang S; Tang J; Feng Y; Sun Y
J Exp Clin Cancer Res; 2022 Dec; 41(1):345. PubMed ID: 36522719
[TBL] [Abstract][Full Text] [Related]
6. NAT10-mediated ac4C tRNA modification promotes EGFR mRNA translation and gefitinib resistance in cancer.
Wei W; Zhang S; Han H; Wang X; Zheng S; Wang Z; Yang C; Wang L; Ma J; Guo S; Wang J; Liu L; Choe J; Lin S
Cell Rep; 2023 Jul; 42(7):112810. PubMed ID: 37463108
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progression.
Deng M; Zhang L; Zheng W; Chen J; Du N; Li M; Chen W; Huang Y; Zeng N; Song Y; Chen Y
J Exp Clin Cancer Res; 2023 Jan; 42(1):9. PubMed ID: 36609449
[TBL] [Abstract][Full Text] [Related]
8. Emerging roles of RNA ac4C modification and NAT10 in mammalian development and human diseases.
Zhang Y; Lei Y; Dong Y; Chen S; Sun S; Zhou F; Zhao Z; Chen B; Wei L; Chen J; Meng Z
Pharmacol Ther; 2024 Jan; 253():108576. PubMed ID: 38065232
[TBL] [Abstract][Full Text] [Related]
9. NAT10-mediated mRNA N4-acetylcytidine modification promotes bladder cancer progression.
Wang G; Zhang M; Zhang Y; Xie Y; Zou J; Zhong J; Zheng Z; Zhou X; Zheng Y; Chen B; Liu C
Clin Transl Med; 2022 May; 12(5):e738. PubMed ID: 35522942
[TBL] [Abstract][Full Text] [Related]
10. PLEK2 promotes cancer stemness and tumorigenesis of head and neck squamous cell carcinoma via the c-Myc-mediated positive feedback loop.
Zhao X; Shu D; Sun W; Si S; Ran W; Guo B; Cui L
Cancer Commun (Lond); 2022 Oct; 42(10):987-1007. PubMed ID: 36002342
[TBL] [Abstract][Full Text] [Related]
11. N-acetyltransferase 10 promotes the progression of oral squamous cell carcinoma through N4-acetylcytidine RNA acetylation of MMP1 mRNA.
Liu Y; Huang H; Zhang CB; Fan HN
Cancer Sci; 2023 Nov; 114(11):4202-4215. PubMed ID: 37705232
[TBL] [Abstract][Full Text] [Related]
12. NAT10-mediated ac
Gao LP; Li TD; Yang SZ; Ma HM; Wang X; Zhang DK
Heliyon; 2024 May; 10(9):e30330. PubMed ID: 38726177
[TBL] [Abstract][Full Text] [Related]
13. NAT10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2.
Liu X; Tan Y; Zhang C; Zhang Y; Zhang L; Ren P; Deng H; Luo J; Ke Y; Du X
EMBO Rep; 2016 Mar; 17(3):349-66. PubMed ID: 26882543
[TBL] [Abstract][Full Text] [Related]
14. NAT10-dependent N
Yan Q; Zhou J; Wang Z; Ding X; Ma X; Li W; Jia X; Gao SJ; Lu C
Nat Commun; 2023 Oct; 14(1):6327. PubMed ID: 37816771
[TBL] [Abstract][Full Text] [Related]
15. NAT10-mediated ac
Ge J; Wang Z; Wu J
Cell Prolif; 2024 Apr; 57(4):e13577. PubMed ID: 38041497
[TBL] [Abstract][Full Text] [Related]
16. NAT10 Promotes Malignant Progression of Lung Cancer via the NF-κB Signaling Pathway.
Liu X; Liu X; Zhuo C; Shen J; Lu K; Sha M; Ye J; Huang J; Han H; Yu H
Discov Med; 2023 Dec; 35(179):936-945. PubMed ID: 38058058
[TBL] [Abstract][Full Text] [Related]
17. N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA.
Zheng X; Wang Q; Zhou Y; Zhang D; Geng Y; Hu W; Wu C; Shi Y; Jiang J
Cancer Commun (Lond); 2022 Dec; 42(12):1347-1366. PubMed ID: 36209353
[TBL] [Abstract][Full Text] [Related]
18. NAT10-mediated AXL mRNA N4-acetylcytidine modification promotes pancreatic carcinoma progression.
Zong G; Wang X; Guo X; Zhao Q; Wang C; Shen S; Xiao W; Yang Q; Jiang W; Shen J; Wan R
Exp Cell Res; 2023 Jul; 428(2):113620. PubMed ID: 37156457
[TBL] [Abstract][Full Text] [Related]
19. NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC.
Tao W; Tian G; Xu S; Li J; Zhang Z; Li J
Cancer Cell Int; 2021 Aug; 21(1):413. PubMed ID: 34362389
[TBL] [Abstract][Full Text] [Related]
20. c-myc-mediated upregulation of NAT10 facilitates tumor development via cell cycle regulation in non-small cell lung cancer.
Wang Z; Huang Y; Lu W; Liu J; Li X; Zhu S; Liu H; Song Y
Med Oncol; 2022 Jul; 39(10):140. PubMed ID: 35834140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
